Hutchison China MediTech Ltd (HCM.OQ)
Latest Key Developments (Source: Significant Developments)
Oct 27 (Reuters) - Hutchison China Meditech Ltd
Oct 16 (Reuters) - Hutchison China Meditech Ltd
Hutchison China Meditech Ltd
Hutchison China Meditech
LONDON, Oct 25 China-based cancer and immunology drug specialist Hutchison China MediTech, or Chi-Med, said it aimed to offer $262 million of American Depositary Shares, subject to market conditions, to help fund development of its pipeline.